Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
YupMD connects patients with independent licensed care providers who may prescribe compounded GLP-1 medications that have not been reviewed or approved by the FDA for safety or effectiveness
,
Direct head-to-head data against tirzepatide showed CagriSema underperforming the highest tirzepatide dose at 84 weeks meaning monotherapy claims of comparable efficacy are not supported by current Phase 3 evidence
We're seeing the same patterns across every pathway we work in
US$ 22.34
US$ 27.06
US$ 25.57
US$ 29.26
US$ 23.33
US$ 28.35
US$ 20.95
